Complete Heart Block
Complete failure of conduction between atria and ventricles (third-degree AV block) with independent atrial and ventricular rhythms. Requires urgent pacing in most acquired cases.
Key Facts
Complete AV dissociation: P waves and QRS complexes are independent with no relationship between them Ventricular escape rate: junctional escape 40-60 bpm (narrow QRS) or ventricular escape 20-40 bpm (broad QRS) Common causes: degenerative conduction disease (most common in elderly), inferior/anterior MI, post-cardiac surgery, drugs Broad QRS escape rhythm carries higher risk of asystole and is more haemodynamically unstable Treatment: permanent pacemaker is definitive treatment for symptomatic or acquired complete heart block Atropine may be used acutely but is often ineffective in infra-nodal block; isoprenaline or temporary pacing preferred Congenital CHB: associated with maternal anti-Ro/La antibodies (neonatal lupus) and structural heart defects Post-inferior MI: may be transient; post-anterior MI indicates extensive septal necrosis with poor prognosis
Overview
Key Facts
Complete heart block (third-degree AV block) is characterised by complete absence of conduction between the atria and ventricles. The atria and ventricles beat independently, with the ventricles relying on an escape rhythm at a rate slower than the sinus rate.
Epidemiology
- Incidence increases with age: rare in young adults, common in elderly
- Leading indication for permanent pacemaker implantation worldwide
- Congenital CHB: incidence ~1 in 15,000-20,000 live births
- Accounts for ~5-10% of acute MI cases with conduction disturbance
Aetiology
Acquired (most common):
- Degenerative: idiopathic fibrosis of the conduction system (Lenegre/Lev disease) — commonest cause in elderly
- Ischaemic: inferior MI (usually transient, AV nodal), anterior MI (usually permanent, infra-nodal)
- Drugs: beta-blockers, CCBs, digoxin toxicity, amiodarone
- Post-surgical: aortic valve replacement, TAVI, septal myectomy
- Inflammatory: myocarditis, endocarditis, rheumatic fever, Lyme disease
- Infiltrative: sarcoidosis, amyloidosis, haemochromatosis
- Autoimmune: SLE (anti-Ro antibodies)
Congenital:
- Maternal anti-Ro (SS-A) and anti-La (SS-B) antibodies (neonatal lupus)
- Structural congenital heart disease (corrected TGA, AV canal defects)
Pathophysiology
- Complete interruption of electrical conduction between atria and ventricles
- Atrial rhythm driven by SA node; ventricular rhythm driven by escape pacemaker
- Junctional escape (narrow QRS, 40-60 bpm): block at AV node, more reliable
- Ventricular escape (broad QRS, 20-40 bpm): block below His bundle, unreliable and prone to asystole
- Cardiac output reduced due to loss of AV synchrony and slow ventricular rate
Clinical Presentation
Typical Presentation
- Symptomatic bradycardia: dizziness, presyncope, syncope (Stokes-Adams attacks)
- Fatigue, exercise intolerance, dyspnoea
- Heart failure symptoms if prolonged
Examination Findings
- Slow regular pulse (escape rate)
- Variable intensity of S1 (due to changing PR relationship)
- Cannon 'a' waves in JVP (atria contracting against closed tricuspid valve)
- Wide pulse pressure
Red Flags
- Syncope or Stokes-Adams attacks
- Haemodynamic instability: hypotension, shock
- Broad QRS escape rhythm (unreliable, risk of asystole)
- New complete heart block in anterior MI
- Heart failure or pulmonary oedema
- Associated with VT/VF (long QT from slow rate may trigger TdP)
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| High-grade second degree block | Some P waves conducted, not all | ECG |
| Sinus bradycardia | Regular slow rate, normal PR, normal AV conduction | ECG |
| Junctional rhythm | No preceding P waves, narrow QRS, rate 40-60 bpm | ECG |
| Hyperkalaemia | Broad QRS, peaked T waves, sine wave pattern | U&Es |
| Hypothyroidism | Bradycardia, fatigue, cold intolerance | TFTs |
| Beta-blocker/CCB overdose | Drug history, bradycardia, hypotension | Drug history, levels |
Diagnosis / Investigation
Bedside
- 12-lead ECG: AV dissociation, escape rhythm rate and QRS width
- Continuous cardiac monitoring: essential — risk of asystole
- Observations: HR, BP, SpO₂
Bloods
- U&Es: potassium, magnesium, calcium
- Troponin: if MI suspected
- Digoxin level: if applicable
- TFTs: hypothyroidism
- FBC, CRP: if inflammatory cause suspected
- Lyme serology: if epidemiological risk
- Anti-Ro/La antibodies: if congenital or young patient with SLE features
Imaging
- Echocardiography: structural heart disease, LV function, valve disease
- Cardiac MRI: sarcoidosis, myocarditis
- Chest X-ray: cardiac size, pulmonary oedema
Special Tests
- Electrophysiology study: rarely needed for complete heart block (diagnosis usually clinical)
- Genetic testing: in congenital cases if familial
Management
Non-pharmacological
- Admit to monitored bed (CCU/HDU)
- External transcutaneous pacing pads applied as standby
- Lie patient flat if hypotensive
Pharmacological
Acute management (per Resuscitation Council UK bradycardia algorithm):
- Atropine 500 mcg IV (repeat up to 3mg): may be effective for nodal block, often ineffective for infra-nodal
- Isoprenaline infusion 1-10 mcg/min: increases ventricular rate; bridging to pacing
- Adrenaline infusion 2-10 mcg/min: if isoprenaline unavailable
- Treat reversible causes: correct electrolytes, stop culprit drugs, treat MI
Surgical/Interventional
- Temporary transvenous pacing: urgently if haemodynamically compromised or broad QRS escape
- Transcutaneous pacing: bridge to transvenous pacing in emergency
- Permanent pacemaker implantation: definitive treatment for acquired symptomatic CHB
- Dual-chamber pacemaker (DDD) is standard
- Rate-responsive pacing for chronotropic incompetence
- NICE recommends within 24-48 hours if no reversible cause
- Congenital CHB: pacemaker if symptomatic, resting HR <50 bpm, broad QRS escape, or associated structural defect
Referral Criteria
- All acquired complete heart block: urgent cardiology referral
- Temporary pacing as bridge to permanent pacemaker
- Post-MI CHB: assess need for permanent pacing before discharge
Prognosis
- Without pacing: significant mortality, especially with broad QRS escape (risk of asystole)
- With permanent pacemaker: near-normal life expectancy
- Post-inferior MI CHB: often transient (resolves in ~70% within 7 days), rarely needs permanent pacing
- Post-anterior MI CHB: poor prognosis (extensive infarction), even with pacing; mortality ~60-80%
- Congenital CHB with narrow QRS and no structural defect: generally favourable with monitoring; pacing if symptomatic
- Pacemaker complications: infection (~1-2%), lead displacement (~2-3%), generator replacement every 7-15 years
Other Relevant Information
Resuscitation Council UK Bradycardia Algorithm Summary
| Step | Action |
|---|---|
| 1 | Assess ABCDE, IV access, monitoring, 12-lead ECG |
| 2 | Identify adverse features: shock, syncope, heart failure, myocardial ischaemia |
| 3 | If adverse features: atropine 500mcg IV |
| 4 | If no response: consider temporary pacing, isoprenaline, or adrenaline |
| 5 | Seek expert help for definitive management |
Escape Rhythm Characteristics
| Level of Block | QRS Width | Escape Rate | Reliability |
|---|---|---|---|
| AV nodal | Narrow | 40-60 bpm | More reliable |
| His bundle | Narrow or wide | 30-50 bpm | Intermediate |
| Below His | Wide | 20-40 bpm | Unreliable, asystole risk |